Search

Your search keyword '"Gudbrandsen M"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Gudbrandsen M" Remove constraint Author: "Gudbrandsen M"
42 results on '"Gudbrandsen M"'

Search Results

1. Brain morphometry in 22q11.2 deletion syndrome: an exploration of differences in cortical thickness, surface area, and their contribution to cortical volume.

2. The Neuroanatomy of Autism Spectrum Disorder Symptomatology in 22q11.2 Deletion Syndrome.

3. Birth of the blues: emotional sound processing in infants exposed to prenatal maternal depression

5. Correction: Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study (Molecular Psychiatry, (2021), 10.1038/s41380-021-01108-y)

6. Brain morphometry in 22q11.2 deletion syndrome: an exploration of differences in cortical thickness, surface area, and their contribution to cortical volume

8. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion

10. Sex differences in frontal lobe connectivity in adults with autism spectrum conditions

12. Sex differences in frontal lobe connectivity in adults with autism spectrum conditions

14. Use of toxicokinetic data in bioaccumulation assessment

15. Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs

16. Unique Functional Neuroimaging Signatures of Genetic Versus Clinical High Risk for Psychosis.

17. Source-based morphometry reveals structural brain pattern abnormalities in 22q11.2 deletion syndrome.

18. Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.

20. Signatures of exposure to childhood trauma in young adults in the structure and neurochemistry of the superior temporal gyrus.

21. Birth of the blues: emotional sound processing in infants exposed to prenatal maternal depression.

22. Maternal depression during pregnancy alters infant subcortical and midbrain volumes.

23. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion.

24. Is postnatal depression a distinct subtype of major depressive disorder? An exploratory study.

25. Examining volumetric gradients based on the frustum surface ratio in the brain in autism spectrum disorder.

26. Atypical measures of diffusion at the gray-white matter boundary in autism spectrum disorder in adulthood.

27. Altered white matter microstructure in 22q11.2 deletion syndrome: a multisite diffusion tensor imaging study.

28. Patterns of Cortical Folding Associated with Autistic Symptoms in Carriers and Noncarriers of the 22q11.2 Microdeletion.

29. Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysis.

30. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.

32. Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness.

33. Neuroanatomical underpinnings of autism symptomatology in carriers and non-carriers of the 22q11.2 microdeletion.

34. Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletion.

35. Father-infant interactions and infant regional brain volumes: A cross-sectional MRI study.

36. Mother-infant interactions and regional brain volumes in infancy: an MRI study.

37. In Vivo Evidence of Reduced Integrity of the Gray-White Matter Boundary in Autism Spectrum Disorder.

38. Olanzapine and risperidone plasma concentration therapeutic drug monitoring: A feasibility study.

39. Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion.

40. Psychiatrists' perspectives on antipsychotic dose and the role of plasma concentration therapeutic drug monitoring.

41. The system N transporter SN2 doubles as a transmitter precursor furnisher and a potential regulator of NMDA receptors.

42. Recovery of cholinesterase activity in the earthworm Eisenia fetida Savigny following exposure to chlorpyrifos.

Catalog

Books, media, physical & digital resources